Chemical synthesis and in vitro biological evaluation of a phosphorylated bisubstrate inhibitor of type 3 17β-hydroxysteroid dehydrogenase-Reference-Cited by-同舟云学术

Chemical synthesis and in vitro biological evaluation of a phosphorylated bisubstrate inhibitor of type 3 17β-hydroxysteroid dehydrogenase

Published:2007-01-01 Issue:2 Volume:22 Page:201-211
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Bérubé Marie¹,Poirier Donald¹

Affiliation:

1. Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, CHUQ-Pavillon CHUL and Université Laval, Québec, G1V 4G2, Canada

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756360601051423

Reference33 articles.

1. Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase

2. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease

3. Role of 17β-Hydroxysteroid Dehydrogenases in Sex Steroid Formation in Peripheral Intracrine Tissues

4. The role of 17 beta-hydroxysteroid dehydrogenases

5. Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Substrate-based Design;Active Site-directed Enzyme Inhibitors;2023-09-13

2. Synthesis of a dansyl-labeled inhibitor of 17β-hydroxysteroid dehydrogenase type 3 for optical imaging;Bioorganic & Medicinal Chemistry Letters;2016-05

3. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases;Current Medicinal Chemistry;2016-03-16

4. Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3;Bioorganic & Medicinal Chemistry;2015-09

5. STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model;Endocrine-Related Cancer;2012-11-06